The key objective was to establish ideal analytical targets by examining human hepatocyte incubation samples with significant-resolution mass spectrometry (HRMS) and to substantiate the outcome in genuine urine specimens and to ascertain AB-FUBINACA's metabolic balance in human liver microsomes and when compared hepatocyte and urine benefits with in silico predictions. https://bethq404zpe8.creacionblog.com/profile